Suppr超能文献

[(11)C]R116301的合成与生物分布,一种有前景的用于中枢神经激肽1(NK(1))受体的正电子发射断层扫描(PET)配体。

Synthesis and biodistribution of [(11)C]R116301, a promising PET ligand for central NK(1) receptors.

作者信息

Van der Mey M, Janssen C G M, Janssens F E, Jurzak M, Langlois X, Sommen F M, Verreet B, Windhorst A D, Leysen J E, Herscheid J D M

机构信息

VU University Medical Center, Department of Nuclear Medicine and PET Research, Location Radionuclide Center, De Boelelaan 1085c, 1081 HV Amsterdam, The Netherlands.

出版信息

Bioorg Med Chem. 2005 Mar 1;13(5):1579-86. doi: 10.1016/j.bmc.2004.12.019.

Abstract

N1-(2,6-Dimethylphenyl)-2-(4-{(2R,4S)-2-benzyl-1-[3,5-di(trifluoromethyl)[carbonyl-(11)C]benzoyl]hexahydro-4-pyridinyl}piperazino)acetamide ([(11)C]R116301) was prepared and evaluated as a potential positron emission tomography (PET) ligand for investigation of central neurokinin(1) (NK(1)) receptors. 1-Bromo-3,5-di(trifluoromethyl)benzene was converted in three steps into 3,5-di(trifluoromethyl)[carbonyl-(11)C]benzoyl chloride, which was reacted with N1-(2,6-dimethylphenyl)-2-{4-[(2R,4S)-2-benzylhexahydro-4-pyridinyl]piperazino}acetamide providing [(11)C]R116301 in 45-57% decay-corrected radiochemical yield. The total synthesis time, from end of bombardment (EOB) to the formulated product, was 35 min. Specific activity (SA) was 82-172 GBq/micromol (n=10) at the end of synthesis. N1-([4-(3)H]-2,6-Dimethylphenyl)-2-(4-{(2R,4S)-2-benzyl-1-[3,5-di(trifluoromethyl)benzoyl]hexahydro-4-pyridinyl}piperazino)acetamide ([(3)H]R116301) was also synthesized (SA: 467 GBq/mmol). The B(max) for [(3)H]R116301 measured in vitro on Chinese hamster ovary cell membranes stably transfected with the human NK(1) receptor was 19.10+/-1.02 pmol/mg protein with an apparent dissociation constant of 0.08+/-0.01 nM. Ex vivo, in vivo and in vitro autoradiography studies with [(3)H]R116301 in gerbils demonstrated a preferential accumulation of the radioactivity in the striatum, olfactory tubercule, olfactory bulb and locus coeruleus. In vivo, the biodistribution of [(11)C]R116301 in gerbils revealed that the highest initial uptake is in the lung, followed by the liver and kidney. In the brain, maximum accumulation was found in the olfactory tubercules (1.10+/-0.08 injected dose (ID)/g 20 min post injection (p.i.)) and the nucleus accumbens (1.00+/-0.12ID/g 10 min p.i.). Tissue/cerebellum concentration ratios for striatum and nucleus accumbens increased with time due to rapid uptake followed by a slow wash out (1.29 and 1.64, respectively, 30 min p.i.). A tissue to cerebellum ratio of 1.33 and 1.62 was also observed for olfactory bulb and olfactory tubercules, respectively (20 min p.i.). In summary, [(11)C]R116301 appears to be a promising radioligand suitable for the visualization of NK(1) receptors in vivo using PET.

摘要

制备了 N1-(2,6-二甲基苯基)-2-(4-{(2R,4S)-2-苄基-1-[3,5-二(三氟甲基)[羰基-(11)C]苯甲酰基]六氢-4-吡啶基}哌嗪基)乙酰胺([(11)C]R116301),并将其作为一种潜在的正电子发射断层扫描(PET)配体进行评估,用于研究中枢神经激肽1(NK(1))受体。1-溴-3,5-二(三氟甲基)苯经三步反应转化为 3,5-二(三氟甲基)[羰基-(11)C]苯甲酰氯,其与 N1-(2,6-二甲基苯基)-2-{4-[(2R,4S)-2-苄基六氢-4-吡啶基]哌嗪基}乙酰胺反应,以 45 - 57%的衰变校正放射化学产率得到[(11)C]R116301。从轰击结束(EOB)到制成制剂产品的总合成时间为 35 分钟。合成结束时比活(SA)为 82 - 172 GBq/μmol(n = 10)。还合成了 N1-([4-(3)H]-2,6-二甲基苯基)-2-(4-{(2R,4S)-2-苄基-1-[3,5-二(三氟甲基)苯甲酰基]六氢-4-吡啶基}哌嗪基)乙酰胺([(3)H]R116301)(比活:467 GBq/mmol)。在稳定转染人 NK(1)受体的中国仓鼠卵巢细胞膜上体外测定[(3)H]R116301 的 B(max)为 19.10±1.02 pmol/mg 蛋白,表观解离常数为 0.08±0.01 nM。用[(3)H]R116301 在沙土鼠中进行的离体、体内和体外放射自显影研究表明,放射性优先在纹状体、嗅结节、嗅球和蓝斑中蓄积。在体内,[(11)C]R116301 在沙土鼠中的生物分布显示,最初摄取最高的是肺,其次是肝和肾。在脑中,在嗅结节(注射后 20 分钟为 1.10±0.08 注射剂量(ID)/g)和伏隔核(注射后 10 分钟为 1.00±0.12ID/g)中发现最大蓄积。由于快速摄取后缓慢清除,纹状体和伏隔核的组织/小脑浓度比随时间增加(注射后 30 分钟时分别为 1.29 和 1.64)。在注射后 20 分钟时,嗅球和嗅结节的组织与小脑的比值分别也为 1.33 和 1.62。总之,[(11)C]R116301 似乎是一种有前景的放射性配体,适用于使用 PET 在体内可视化 NK(1)受体。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验